Commercial Court

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024

Retrieved on: 
Wednesday, January 17, 2024
Sale, Euronext Growth, Euronext Paris, Patient, Commercial Court

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024

Key Points: 
  • Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024
    Paris, France, January 17, 2024 – 5:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces that the Paris Commercial Court has postponed its decision on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings to January 31, 2024.
  • The Company will apply to Euronext Paris for its shares to be suspended from that date.
  • Pixium draws investors’ attention to the fact that, given the price offered by the prospective buyer and the Company’s level of indebtedness, the sale proceeds received in the event of a favourable decision by the Commercial Court will not allow a total or partial reimbursement of shareholders.

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings

Retrieved on: 
Wednesday, January 17, 2024
Sale, Euronext Growth, Patient, Commercial Court

Paris, France, January 17, 2024 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces that the decision of the Paris Commercial Court on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings has been postponed to a later date, which will be communicated by the Company as soon as it becomes aware of it.

Key Points: 
  • Paris, France, January 17, 2024 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces that the decision of the Paris Commercial Court on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings has been postponed to a later date, which will be communicated by the Company as soon as it becomes aware of it.
  • Pixium draws investors’ attention to the fact that, given the price offered by the prospective buyer and the Company’s level of indebtedness, the sale proceeds received in the event of a favourable decision by the Commercial Court will not allow a total or partial reimbursement of shareholders.

Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024

Retrieved on: 
Monday, December 18, 2023
Commercial Court, Patient, Euronext Growth, Sale

Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024

Key Points: 
  • Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024
    Paris, France, December 18, 2023 – 7:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces that following today's hearing, the Paris Commercial Court will issue its decision on January 16, 2024 on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings.
  • In the event of the opening of judicial liquidation proceedings, Euronext will delist Pixium’s shares.
  • Pixium draws investors’ attention to the fact that, given the current offer and the Company's level of indebtedness, the sale proceeds received in the event of a favourable decision by the Commercial Court will not allow a total or partial reimbursement of shareholders.

Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023

Retrieved on: 
Monday, December 4, 2023
Commercial Court, Commercial, Euronext Growth, Sale, Court, Patient

Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023

Key Points: 
  • Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023
    Paris, France, December 4, 2023 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces that the Paris Commercial Court will hold a hearing to examine the takeover offer received by the court-appointed administrators and to decide on the outcome of the Company’s reorganization proceedings on December 18, 2023.
  • As a reminder, only one takeover offer was submitted before the deadline for submission of offers, which was set to November 20, 2023 at noon.
  • The candidate will have until December 13, 2023 to improve its offer.
  • Concurrently with the decision of the Commercial Court ruling on the takeover offer, the Court will order the Company's judicial liquidation.

Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators

Retrieved on: 
Monday, November 20, 2023
Sale, Hearing, Commercial Court, Patient, CET, Euronext Growth, Mnemos EP, Commercial Court (Victoria)

Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators

Key Points: 
  • Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators
    Paris, France, November 20, 2023 – 5:45 pm (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, whose safeguard proceedings (procédure de sauvegarde) were converted into receivership (redressement judiciaire) by decision of the Paris Commercial Court on November 13, 2023, announces that the court-appointed administrators have today received a takeover offer for the assets and activities of Pixium.
  • The date for the hearing to examine the takeover offer will be set by the Commercial Court by the end of November.
  • The Company draws investors’ attention to the fact that, given the current offer and the Company’s level of indebtedness, the sale proceeds received in the context of the Company’s insolvency proceedings do not allow a total or partial reimbursement of shareholders.

Pixium Vision announces the conversion of the safeguard proceedings into receivership

Retrieved on: 
Monday, November 13, 2023
Interest, Commercial Court, Euronext Growth, Confidentiality, Patient, Mnemos EP, Hearing

As announced on October 18, 2023, in the absence of a solution to strengthen its financial situation and secure its cash runway during the safeguard proceedings, Pixium together with the court-appointed administrators, filed a request with the Commercial Court of Paris for the conversion of the safeguard proceedings into receivership.

Key Points: 
  • As announced on October 18, 2023, in the absence of a solution to strengthen its financial situation and secure its cash runway during the safeguard proceedings, Pixium together with the court-appointed administrators, filed a request with the Commercial Court of Paris for the conversion of the safeguard proceedings into receivership.
  • This request was examined and approved by the Commercial Court of Paris at the hearing of November 13, 2023.
  • Interested candidates are invited to contact the court-appointed administrators, SCP Abitbol & Rousselet, represented by Joanna Rousselet, and Selarl FHB, represented Hélène Bourbouloux.
  • The market will be regularly informed on the progress of the procedure and, more generally, on the financial situation of Pixium.

RALLYE S.A.: Opening of ad hoc proceedings

Retrieved on: 
Thursday, October 26, 2023
Commercial Court, Rallying, Groupe Casino

Rallye, Foncière Euris, Finatis and Euris announce that they have applied for and obtained today from the President of the Commercial Court of Paris the opening of ad hoc mandate proceedings to their benefit under the aegis of SELAFA MJA (Me Valérie Leloup-Thomas) and SELARL Fides (Me Bernard Corre), for a period of 6 months, for the purpose of:

Key Points: 
  • Rallye, Foncière Euris, Finatis and Euris announce that they have applied for and obtained today from the President of the Commercial Court of Paris the opening of ad hoc mandate proceedings to their benefit under the aegis of SELAFA MJA (Me Valérie Leloup-Thomas) and SELARL Fides (Me Bernard Corre), for a period of 6 months, for the purpose of:
    for Rallye to support its subsidiary Casino in accordance with its press release dated 18 October 2023 and to draw the appropriate conclusions in due course from the effective completion of Casino's ongoing financial restructuring, in particular with regard to its safeguard plan; and
    for Foncière Euris, Finatis and Euris to draw the appropriate conclusions in due course from the effective completion of Casino's ongoing financial restructuring, in particular with regard to their safeguard plans.

Pixium Vision announces its financial results for H1 2023 and provides update

Retrieved on: 
Thursday, October 26, 2023
Mnemos EP, State, Commercial Court, Bank statement, Euronext Growth, EUR, CET, Commercial Court (Victoria), European, CIC, Patient, Security (finance), Risk management, Cryptocurrency, Bpifrance

The H1 2023 financial statements were approved by Pixium Vision’s Board of Directors at its meeting on 25 October 2023.

Key Points: 
  • The H1 2023 financial statements were approved by Pixium Vision’s Board of Directors at its meeting on 25 October 2023.
  • Our request for an accelerated payment of the Research Tax Credit for the year 2022 for an amount of EUR 1,829,961 was granted and paid during H1 2023.
  • Freeze of the maturities due under the State-guaranteed loans granted to the Company by Bpifrance and CIC was extended until end of September 2023.
  • Given the above, our auditors were unable to express a conclusion on the condensed half-yearly consolidated financial statements.

Pixium Vision announces the opening of safeguard proceedings

Retrieved on: 
Monday, October 9, 2023
Acquisition, Mnemos EP, Euronext Growth, Court, Risk, Bank statement, Patient, CET, Euronext Paris, Observation, Commercial Court, Research, Sale, Security (finance), Risk management

Paris, France, October 9, 2023 – 19:00 (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX) (the “Company”), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces the opening today of safeguard proceedings by the Commercial Court of Paris.

Key Points: 
  • Paris, France, October 9, 2023 – 19:00 (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnemo: ALPIX) (the “Company”), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces the opening today of safeguard proceedings by the Commercial Court of Paris.
  • Considering such liquidity risk over a maximum 2-month horizon and the absence of new financing to date, Pixium Vision therefore requested the opening of safeguard proceedings with the Commercial Court of Paris.
  • In this context, Pixium Vision has applied to Euronext Paris for the resumption of the listing of its shares as of the opening of the markets on October 10, 2023.
  • As a consequence of the opening of such safeguard proceedings, the Company is not in a position to publish its H1 2023 condensed financial statements, which will therefore be published at a later date.

Seladore Legal LLP: Jailed Russian businessman, Ziyavudin Magomedov files US$14 billion claim in the English High Court against TPG, DP World, Transneft, Rosatom and others, alleging Russian state-led conspiracy

Retrieved on: 
Wednesday, September 27, 2023
Brick Court Chambers, Commercial Court, DP World, King's Bench Division, Justice, High Court of Justice, The Wall Street Journal, Free port of Vladivostok, World cup, Port, Wall Street, High court, Singapore International Commercial Court, TPG, Grain, Muhammad (name), FSB, NCSP, KCS, TPG Inc., Cryptocurrency, Drug, FESCO, Black Sea

Simultaneously, he is fighting concerted efforts by prosecutors and business rivals to confiscate his estimated multibillion-dollar business empire.

Key Points: 
  • Simultaneously, he is fighting concerted efforts by prosecutors and business rivals to confiscate his estimated multibillion-dollar business empire.
  • Mr Magomedov co-owned the vital NCSP port in Novorossiysk which handles Russia's oil and grain exports from the Black Sea.
  • The legal claim conservatively estimates the value of the claimants' interest in FESCO at $8.8 billion, and their interest in NCSP at $5.0 billion.
  • The combined claim of $13.8 billion it is the largest ever claim brought in the English High Court outside the collective redress regime.